Owned by Akzo-Nobel, Intervet was one of the three companies that made up Akzo-Nobel's pharmaceutical division.  Completing the division are Organon, a human pharmaceutical company (its first product was insulin in 1923),  and Diosynth, which makes biotech and traditional pharmaceutical raw materials (among them, insulin extracted from animal pancreases since 1923). 
Intervet merged with Schering-Plough Animal Health; both companies have now merged with Merck. The Merck merger created the second-largest veterinary pharmaceutical company in the world. On June 29, 2011, it was announced that Intervet/Schering-Plough Animal Health would now be known as Merck Animal Health in the United States and Canada and called MSD Animal Health elsewhere.
- ↑ Intervet International Website
- ↑ Akzo Nobel-Companies. Akzo-Nobel (2005).
- ↑ Organon International History-1920-Products. Organon.
- ↑ Report on Insulin in Europe-Insulin Committee-page 26. University of Toronto (1925).
- ↑ Diosynth & Biochemistry. Diosynth.
- ↑ Diosynth Products and Technology-Page 3. Diosynth.
- ↑ Diosynth Company History. Diosynth.
- ↑ Diosynth France, Usine Saint Charles-Extraction Plant for insulin.
- ↑ Intervet/Schering-Plough, Merial Call Off Merger. DVM360 (23 March 2011).
- ↑ Merck Announces New Name For Its Animal Health Division (29 June 2011).
Pages in category "Intervet"
This category contains only the following page.